Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2023 ▲▼ | Q3 2023 ▲▼ | Change ▲▼ | Q2 2023 ▲▼ | Q3 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 3,743,450 | 3,743,450 | 0 | 56,676 | 78,126 | 43.39% | +21,450 |
| Cymabay Therapeutics, Inc. | 1,787,094 | 1,787,094 | 0 | 19,569 | 26,646 | 14.80% | +7,077 |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,849,947 | 0 | 19,572 | 16,872 | 9.37% | -2,701 |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 875,000 | 0 | 18,314 | 12,705 | 7.06% | -5,609 |
| Aclaris Therapeutics, Inc.(ACRS) | 2,808,034 | 2,808,034 | 0 | 29,119 | 19,235 | 10.68% | -9,884 |
| Kinnate Biopharma Inc. | 9,671,643 | 9,671,643 | 0 | 29,305 | 13,540 | 7.52% | -15,765 |
| Lyell Immunopharma, Inc. | 9,700,000 | 8,784,813 | -915,187 | 30,846 | 12,914 | 7.17% | -17,932 |